Simona Hisirová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simona Hisirová has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ján Király
Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Kosice, 041 81 Kosice, Slovakia
5 shared publications - Nikola Dančová
Department of Public Veterinary Medicine and Animal Welfare, the University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
5 shared publications - Patrícia Hudecová
Department of Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
5 shared publications - Vanda Hajdučková
Department of Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
5 shared publications - Gabriela Gregová
Department of Public Veterinary Medicine and Animal Welfare, the University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
4 shared publications - Stanislav Lauko
Department of Microbiology and Immunology, The University of Veterinary Medicine and Pharmacy in Košice, 041 81 Košice, Slovakia
2 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 1017
Exploitation of Nanoparticle–Essential Oil Combinations to Enhance the Efficacy of Antimicrobial Agents Against Staphylococcus equorum
Background: This study evaluated the antibacterial, antibiofilm, and biofilm eradication activities of biogenically synthesized silver nanoparticles (AgNPs-L, AgNPs-R) mediated by extracts of Lavandula angustifolia and Salvia rosmarinus, individually and in combination with their respective essential oils (EOs) and ampicillin (AMP), against a multidrug-resistant biofilm-forming Staphylococcus equorum strain. Physicochemical characterization confirmed the successful biosynthesis of spherical AgNPs-L (10–25 nm) and AgNPs-R (5–15 nm). Individual treatments exhibited distinct antibacterial activity, with MIC values of 25 µg/mL for AgNPs-L, 12.5 µg/mL for AgNPs-R, and 0.1% (v/v) for both EOs; however, they showed no ability to eradicate preformed biofilms. Dual AgNPs/EO combinations at subinhibitory concentrations demonstrated borderline additive effects (FICI = 0.501) and significantly potentiated antibacterial and antibiofilm activity compared with individual treatments. Triple AgNPs/EO/AMP combinations exhibited the most pronounced biological effects, with predominantly additive interactions depending on AMP concentration. Lavender-based triple combinations achieved up to 63.9% inhibition of planktonic growth, 78.1% prevention of biofilm formation, and 37.3% eradication of mature biofilms, whereas rosemary-based combinations resulted in 57.1%, 69.4%, and 42.7% inhibition, respectively. These findings highlight the potential of multi-component systems integrating biogenic nanomaterials, phytochemicals, and conventional antibiotics as a promising strategy to enhance antimicrobial efficacy against persistent biofilm-forming non-aureus staphylococci.
- 17 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 1017
Open AccessExploitation of Nanoparticle–Essential Oil Combinations to Enhance the Efficacy of Antimicrobial Agents Against Staphylococcus equorum
Background: This study evaluated the antibacterial, antibiofilm, and biofilm eradication activities of biogenically synthesized silver nanoparticles (AgNPs-L, AgNPs-R) mediated by extracts of Lavandula angustifolia and Salvia rosmarinus, individually and in combination with their respective essential oils (EOs) and ampicillin (AMP), against a multidrug-resistant biofilm-forming Staphylococcus equorum strain. Physicochemical characterization confirmed the successful biosynthesis of spherical AgNPs-L (10–25 nm) and AgNPs-R (5–15 nm). Individual treatments exhibited distinct antibacterial activity, with MIC values of 25 µg/mL for AgNPs-L, 12.5 µg/mL for AgNPs-R, and 0.1% (v/v) for both EOs; however, they showed no ability to eradicate preformed biofilms. Dual AgNPs/EO combinations at subinhibitory concentrations demonstrated borderline additive effects (FICI = 0.501) and significantly potentiated antibacterial and antibiofilm activity compared with individual treatments. Triple AgNPs/EO/AMP combinations exhibited the most pronounced biological effects, with predominantly additive interactions depending on AMP concentration. Lavender-based triple combinations achieved up to 63.9% inhibition of planktonic growth, 78.1% prevention of biofilm formation, and 37.3% eradication of mature biofilms, whereas rosemary-based combinations resulted in 57.1%, 69.4%, and 42.7% inhibition, respectively. These findings highlight the potential of multi-component systems integrating biogenic nanomaterials, phytochemicals, and conventional antibiotics as a promising strategy to enhance antimicrobial efficacy against persistent biofilm-forming non-aureus staphylococci.
- Open Access
- 27 February 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (3) , 250
Effect of Biosynthesized Gold and Silver Nanoparticles Using Alchemilla vulgaris Extract and Their Synergistic Action with Subinhibitory Concentrations of Ampicillin Against Staphylococci
Background: Staphylococci, recognized for their virulence and antibiotic resistance, are important in both human and veterinary medicine. Loss of sensitivity to beta-lactam antibiotics, such as ampicillin, complicates therapy, prompting the search for alternative antibacterials or ways to increase drug efficacy. Silver and gold nanoparticles (AgNPs, AuNPs) are promising on their own or in combination with antibiotics. Methods: The aim of this study is to compare the biological activity of pure, washed AgNPs and AuNPs with biosynthesized nanoparticles from Alchemilla vulgaris (AgNPs-Av and AuNPs-Av). Their antibacterial, antibiofilm, and biofilm-eradication effects on the tested antibiotic-resistant, biofilm-forming staphylococci (Methicillin-resistant Staphylococcus aureus (MRSA) and multiresistant Non-aureus staphylococci and mammaliicocci (NASM)) were evaluated using in vitro microdilution methods. Results: AgNPs-Av and AuNPs-Av inhibited bacterial growth at 50 μg/mL, while a significant suppression of biofilm formation was observed at just 25 μg/mL. Our research showed that neither AuNPs-Av nor AuNPs disrupts bacterial biofilm. AgNPs-Av effectively eradicated the biofilm at 50 μg/mL. NPs and ampicillin at subinhibitory antibiotic concentrations against the tested staphylococci. The results showed significant antibacterial and antibiofilm effects (p = 0.001). Partially, biofilm-eradication activity and strong antibiotic potentiation were also detected. Conclusions: These findings highlight the importance of rational combination therapy to improve antibiotic effectiveness and reduce bacterial resistance.
- 27 February 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (3) , 250
Open AccessEffect of Biosynthesized Gold and Silver Nanoparticles Using Alchemilla vulgaris Extract and Their Synergistic Action with Subinhibitory Concentrations of Ampicillin Against Staphylococci
Background: Staphylococci, recognized for their virulence and antibiotic resistance, are important in both human and veterinary medicine. Loss of sensitivity to beta-lactam antibiotics, such as ampicillin, complicates therapy, prompting the search for alternative antibacterials or ways to increase drug efficacy. Silver and gold nanoparticles (AgNPs, AuNPs) are promising on their own or in combination with antibiotics. Methods: The aim of this study is to compare the biological activity of pure, washed AgNPs and AuNPs with biosynthesized nanoparticles from Alchemilla vulgaris (AgNPs-Av and AuNPs-Av). Their antibacterial, antibiofilm, and biofilm-eradication effects on the tested antibiotic-resistant, biofilm-forming staphylococci (Methicillin-resistant Staphylococcus aureus (MRSA) and multiresistant Non-aureus staphylococci and mammaliicocci (NASM)) were evaluated using in vitro microdilution methods. Results: AgNPs-Av and AuNPs-Av inhibited bacterial growth at 50 μg/mL, while a significant suppression of biofilm formation was observed at just 25 μg/mL. Our research showed that neither AuNPs-Av nor AuNPs disrupts bacterial biofilm. AgNPs-Av effectively eradicated the biofilm at 50 μg/mL. NPs and ampicillin at subinhibitory antibiotic concentrations against the tested staphylococci. The results showed significant antibacterial and antibiofilm effects (p = 0.001). Partially, biofilm-eradication activity and strong antibiotic potentiation were also detected. Conclusions: These findings highlight the importance of rational combination therapy to improve antibiotic effectiveness and reduce bacterial resistance.
- Open Access
Prevalence of Biofilm-Forming and Antibiotic-Resistant Coagulase-Negative Staphylococci Isolated from Hospitalized Patients in an Orthopedic Clinic
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) are a major cause of infectious diseases, owing to their ability to form biofilms and colonize community and hospital environments. MRCoNS strains were identified using biochemical tests, an MALDI-TOF MS analyzer, and PCR-based 16S rRNA gene confirmation. This study was designed to assess antibiotic resistance and biofilm-forming capacity and to determine the presence of the mecA, mecC, agrA, srtA, icaABCD, bap, fnbAB, and clfAB genes in MRCoNS isolates. From patients undergoing random screening during hospitalization in the Orthopedics Clinic in Slovakia, 28 strains of MRCoNS were identified: S. epidermidis (n = 10), S. hominis (n = 8), S. haemolyticus (n = 4), S. lugdunensis (n = 3), while S. simulans, S. pasteuri, and S. warneri were detected only once. The highest rates of resistance were observed for ampicillin, oxacillin, rifampicin, trimethoprim (100%), and erythromycin (62%). The mecA gene was detected in 12 analyzed isolates. In 12 isolates, MDR, strong efflux pump activity, and strong or moderate biofilm formation were simultaneously detected. Our findings highlight the problems posed by biofilm-forming, resistant CoNS in hospitalized patients and the importance of diagnostics, separation, rapid treatment, and proper hospital hygiene.
Open AccessPrevalence of Biofilm-Forming and Antibiotic-Resistant Coagulase-Negative Staphylococci Isolated from Hospitalized Patients in an Orthopedic Clinic
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) are a major cause of infectious diseases, owing to their ability to form biofilms and colonize community and hospital environments. MRCoNS strains were identified using biochemical tests, an MALDI-TOF MS analyzer, and PCR-based 16S rRNA gene confirmation. This study was designed to assess antibiotic resistance and biofilm-forming capacity and to determine the presence of the mecA, mecC, agrA, srtA, icaABCD, bap, fnbAB, and clfAB genes in MRCoNS isolates. From patients undergoing random screening during hospitalization in the Orthopedics Clinic in Slovakia, 28 strains of MRCoNS were identified: S. epidermidis (n = 10), S. hominis (n = 8), S. haemolyticus (n = 4), S. lugdunensis (n = 3), while S. simulans, S. pasteuri, and S. warneri were detected only once. The highest rates of resistance were observed for ampicillin, oxacillin, rifampicin, trimethoprim (100%), and erythromycin (62%). The mecA gene was detected in 12 analyzed isolates. In 12 isolates, MDR, strong efflux pump activity, and strong or moderate biofilm formation were simultaneously detected. Our findings highlight the problems posed by biofilm-forming, resistant CoNS in hospitalized patients and the importance of diagnostics, separation, rapid treatment, and proper hospital hygiene.
- Open Access
- 25 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2449
Characterization and Antimicrobial Resistance Profiles of Biofilm Forming Strains of Staphylococcus aureus Isolated from Skin Lesions
Staphylococcus aureus is an important human pathogen known for its versatility and ability to cause a wide range of infections. The aim of this study was to isolate and identify S. aureus from skin lesions from human patients, to determine antimicrobial resistance and biofilm formation potential at phenotypic and genotypic levels, as well as to verify the activity of efflux pump production. Out of 51 samples collected from skin lesions of various etiologies, 13 isolates were identified as S. aureus. All isolates showed the ability to form biofilms, which correlated with the presence of the icaABCD, agrA, srtA, clfAB, and fnbAB genes, while the bap gene was absent. The highest rates of resistance were observed for ampicillin (69.2%) and gentamicin (46.2%), as well as for erythromycin and clindamycin (38.5%). The mecA gene was present in two isolates, but phenotypic resistance to methicillin was confirmed in only one of them, suggesting possible heterogeneous expression or regulated activity of resistance mechanisms. The mecC gene was not present in any isolate. Efflux pump production was observed in only three isolates, showing weak to intermediate levels. These findings indicate the high biofilm potential and variable antimicrobial resistance of S. aureus clinical isolates, which pose a challenge for the treatment of emerging skin infections.
- 25 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2449
Open AccessCharacterization and Antimicrobial Resistance Profiles of Biofilm Forming Strains of Staphylococcus aureus Isolated from Skin Lesions
Staphylococcus aureus is an important human pathogen known for its versatility and ability to cause a wide range of infections. The aim of this study was to isolate and identify S. aureus from skin lesions from human patients, to determine antimicrobial resistance and biofilm formation potential at phenotypic and genotypic levels, as well as to verify the activity of efflux pump production. Out of 51 samples collected from skin lesions of various etiologies, 13 isolates were identified as S. aureus. All isolates showed the ability to form biofilms, which correlated with the presence of the icaABCD, agrA, srtA, clfAB, and fnbAB genes, while the bap gene was absent. The highest rates of resistance were observed for ampicillin (69.2%) and gentamicin (46.2%), as well as for erythromycin and clindamycin (38.5%). The mecA gene was present in two isolates, but phenotypic resistance to methicillin was confirmed in only one of them, suggesting possible heterogeneous expression or regulated activity of resistance mechanisms. The mecC gene was not present in any isolate. Efflux pump production was observed in only three isolates, showing weak to intermediate levels. These findings indicate the high biofilm potential and variable antimicrobial resistance of S. aureus clinical isolates, which pose a challenge for the treatment of emerging skin infections.
- Open Access
- 25 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (4) , 735
Resistance Genes and Virulence Factor Genes in Coagulase-Negative and Positive Staphylococci of the Staphylococcus intermedius Group (SIG) Isolated from the Dog Skin
Staphylococci are common pathogens in dogs, causing a variety of dermatological problems. This study aimed to characterize the prevalence, antibiotic resistance, and biofilm-forming potential of Staphylococcus species isolated from the skin of shelter dogs. Overall, 108 samples were collected from the hairless skin areas of dogs in a shelter over one year. Isolates were cultured using standard microbiological methods and identified through biochemical testing, MALDI-TOF MS, and multiplex PCR. A total of 67 Staphylococcus isolates were identified, with S. pseudintermedius being the most prevalent. Antibiotic susceptibility was assessed using disk diffusion and MIC methods, revealing high resistance to ampicillin, erythromycin, and tetracycline. Notably, 12 multidrug-resistant SIG (S. intermedius group; S. pseudintermedius) and 4 CoNS strains (coagulase-negative staphylococci; S. equorum) were identified. Biofilm production was evaluated using a crystal violet assay, showing variable biofilm-forming capabilities among isolates and PCR, to confirm genes associated with biofilm formation. These findings highlight the presence of multidrug-resistant Staphylococcus species in shelter dogs, emphasizing the need for careful monitoring and antibiotic stewardship to manage potential risks to both animal and human health.
- 25 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (4) , 735
Open AccessResistance Genes and Virulence Factor Genes in Coagulase-Negative and Positive Staphylococci of the Staphylococcus intermedius Group (SIG) Isolated from the Dog Skin
Staphylococci are common pathogens in dogs, causing a variety of dermatological problems. This study aimed to characterize the prevalence, antibiotic resistance, and biofilm-forming potential of Staphylococcus species isolated from the skin of shelter dogs. Overall, 108 samples were collected from the hairless skin areas of dogs in a shelter over one year. Isolates were cultured using standard microbiological methods and identified through biochemical testing, MALDI-TOF MS, and multiplex PCR. A total of 67 Staphylococcus isolates were identified, with S. pseudintermedius being the most prevalent. Antibiotic susceptibility was assessed using disk diffusion and MIC methods, revealing high resistance to ampicillin, erythromycin, and tetracycline. Notably, 12 multidrug-resistant SIG (S. intermedius group; S. pseudintermedius) and 4 CoNS strains (coagulase-negative staphylococci; S. equorum) were identified. Biofilm production was evaluated using a crystal violet assay, showing variable biofilm-forming capabilities among isolates and PCR, to confirm genes associated with biofilm formation. These findings highlight the presence of multidrug-resistant Staphylococcus species in shelter dogs, emphasizing the need for careful monitoring and antibiotic stewardship to manage potential risks to both animal and human health.